Relieves bronchospasm. ANDA 77788, held by Chartwell Rx. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 77788 (Albuterol Sulfate), held by Chartwell Rx, was first approved by FDA on Jun 26, 2007, with 0 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Albuterol Sulfate Syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 26, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 2MG BASE/5ML · syrup;oral | Albuterol Sulfate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters